Similar articles for PMID: 23909468

Year	Number of Results
1993	1
1997	1
2001	1
2002	1
2003	1
2005	2
2006	8
2007	9
2008	3
2009	8
2010	7
2011	15
2012	23
2013	28
2014	24
2015	13
2016	6
2017	5
2018	2
2019	6
2020	5
2021	5
2022	2
2023	2
2024	0

1

A multi-centre retrospective study of rituximab use in the treatment of relapsed or resistant warm autoimmune haemolytic anaemia.

Maung SW, Leahy M, O'Leary HM, Khan I, Cahill MR, Gilligan O, Murphy P, McPherson S, Jackson F, Ryan M, Hennessy B, McHugh J, Goodyer M, Bacon L, O'Gorman P, Nee A, O'Dwyer M, Enright H, Saunders J, O'Keeffe D. Maung SW, et al. Br J Haematol. 2013 Oct;163(1):118-22. doi: 10.1111/bjh.12486. Epub 2013 Aug 2. Br J Haematol. 2013. PMID: 23909468 Free article.

2

Efficacy and safety of rituximab in adults' warm antibody autoimmune haemolytic anemia: retrospective analysis of 27 cases.

Bussone G, Ribeiro E, Dechartres A, Viallard JF, Bonnotte B, Fain O, Godeau B, Michel M. Bussone G, et al. Am J Hematol. 2009 Mar;84(3):153-7. doi: 10.1002/ajh.21341. Am J Hematol. 2009. PMID: 19123460 Free article. Clinical Trial.

3

Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia.

Zaja F, Volpetti S, Chiozzotto M, Puglisi S, Isola M, Buttignol S, Fanin R. Zaja F, et al. Am J Hematol. 2012 Sep;87(9):886-9. doi: 10.1002/ajh.23272. Epub 2012 Jun 20. Am J Hematol. 2012. PMID: 22718483 Free article. Clinical Trial.

4

A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia.

Birgens H, Frederiksen H, Hasselbalch HC, Rasmussen IH, Nielsen OJ, Kjeldsen L, Larsen H, Mourits-Andersen T, Plesner T, Rønnov-Jessen D, Vestergaard H, Klausen TW, Schöllkopf C. Birgens H, et al. Br J Haematol. 2013 Nov;163(3):393-9. doi: 10.1111/bjh.12541. Epub 2013 Aug 24. Br J Haematol. 2013. PMID: 23981017 Free article. Clinical Trial.

5

Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.

Dierickx D, Verhoef G, Van Hoof A, Mineur P, Roest A, Triffet A, Kentos A, Pierre P, Boulet D, Bries G, Lê PQ, Janssens A, Delannoy A. Dierickx D, et al. J Intern Med. 2009 Nov;266(5):484-91. doi: 10.1111/j.1365-2796.2009.02126.x. Epub 2009 Apr 27. J Intern Med. 2009. PMID: 19549092 Free article.

6

Sustained response to low-dose rituximab in idiopathic autoimmune hemolytic anemia.

Barcellini W, Zaja F, Zaninoni A, Imperiali FG, Di Bona E, Fattizzo B, Consonni D, Cortelezzi A, Zanella A. Barcellini W, et al. Eur J Haematol. 2013 Dec;91(6):546-51. doi: 10.1111/ejh.12199. Epub 2013 Oct 3. Eur J Haematol. 2013. PMID: 24033754 Clinical Trial.

7

Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia.

Peñalver FJ, Alvarez-Larrán A, Díez-Martin JL, Gallur L, Jarque I, Caballero D, Díaz-Mediavilla J, Bustelos R, Fernández-Aceñero MJ, Cabrera JR; Multi-institutional Retrospective Study on the use of rituximab in refractory AIHA. Peñalver FJ, et al. Ann Hematol. 2010 Nov;89(11):1073-80. doi: 10.1007/s00277-010-0997-y. Epub 2010 Jun 5. Ann Hematol. 2010. PMID: 20526716

8

A case of autoimmune haemolytic anaemia achieving complete response with rituximab.

Dev M, Mushtaq N, Faisal A. Dev M, et al. J Pak Med Assoc. 2014 Jun;64(6):700-2. J Pak Med Assoc. 2014. PMID: 25252495

9

[The long-term efficacy and safety of rituximab combined with cyclophosphamide in treatment of seven patients with refractory and recurrent autoimmune hemolytic anemia].

Liu H, Xing LM, Wang HQ, Wu YH, Qu W, Liang Y, Wang GJ, Song J, Wang XM, Guan J, Li LJ, Fu R, Shao ZH. Liu H, et al. Zhonghua Nei Ke Za Zhi. 2012 Jun;51(6):456-9. Zhonghua Nei Ke Za Zhi. 2012. PMID: 22943757 Clinical Trial. Chinese.

10

Addition of rituximab to standard therapy improves response rate and progression-free survival in relapsed or refractory thrombotic thrombocytopenic purpura and autoimmune haemolytic anaemia.

Heidel F, Lipka DB, von Auer C, Huber C, Scharrer I, Hess G. Heidel F, et al. Thromb Haemost. 2007 Feb;97(2):228-33. doi: 10.1160/th06-09-0499. Thromb Haemost. 2007. PMID: 17264951

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

151 results

Results by year